The high levels of ETS1 was associated with poor prognosis as evident from Kaplan-Meier analysis of a cohort of 97 HNSCC patients, which showed that patients with high ETS1 expression had a statistically significant overall worse outcome than patients with low expression (Fig 1D). The gene discussed is ETS1; the disease is head and neck squamous cell carcinoma.